Novo Nordisk: New data in sight:

wallstreet-online.de/nachricht/21634779-aktie-haussiert-novo-nordisk-gewinn-hammer-zahlenfeuerwerk-haken

wotwitt Nov 04

Novo Nordisk: Profit Hammer! But the Number Showcase Has a Catch: The Wegovy pill is booming, Novo Nordisk raises its forecast again. But the quarterly report ...

deraktionaer.de/artikel/pharma-biotech/novo-nordisk-mit-zahlen-endlich-ist-das-der-befreiungsschlag-20432971.html

Nov 04

Novo Nordisk with figures - | finally! Is this the breakthrough?: Novo Nordisk exceeds expectations in Q3 2026, increases revenue to DKK 79 ...

deraktionaer.de/artikel/pharma-biotech/novo-nordisk-drei-wichtige-termine-voraus-20429702.html

Nov 01

Novo Nordisk: Three important dates ahead!: Eli Lilly reaches an all-time high, while Novo Nordisk awaits key November dates, including its quarterly report and ...

deraktionaer.de/artikel/pharma-biotech/eli-lilly-schiesst-nach-zahlen-auf-ein-neues-rekordhoch-und-zeigt-novo-die-ruecklichter-20428193.html

Oct 29

Eli Lilly shoots to a new record high according to figures - | and leaves Novo in the dust

wallstreet-online.de/nachricht/21588504-klatsche-gericht-lilly-6-mal-wert-novo-abstand-groesser

wotwitt Oct 27

Lilly is worth 6 times as much as Novo: Will the gap now widen even further?: Novo Nordisk fails with an emergency application against Lilly's advertising ...

boerse-online.de/nachrichten/aktien/dax-faellt-novo-nordisk-meta-nvidia-porsche-beiersdorf-apple-eli-lilly-cancom-20425362.html

BÖRSE ONLINE

Oct 27

DAX falls - | Novo Nordisk, Meta, Nvidia, Porsche, Beiersdorf, Apple, Eli Lilly, Cancom

deraktionaer.de/artikel/pharma-biotech/zwischen-value-falle-turnaround-und-dividenden-chance-was-bei-novo-nordisk-wirklich-zaehlt-20414131.html

Oct 10

Between value trap, turnaround and dividend opportunity: What really matters at Novo Nordisk

wallstreet-online.de/nachricht/21446877-2-6-milliarden-wette-novo-nordisk-bringt-milliarden-deal-endlich-wende

wotwitt Sep 29

Novo Nordisk: Will this billion-dollar deal finally bring about a turnaround?: The Danish pharmaceutical company Novo Nordisk is under pressure to revive its ...

diepresse.com/41288262/novo-nordisk-nimmt-jetzt-mittel-gegen-haarausfall-ins-visier

Die Presse

Sep 23

After the weight-loss injection: Novo Nordisk is now setting its sights on treatments for hair loss

deraktionaer.de/artikel/pharma-biotech/abnehmen-bevor-es-ernst-wird-novo-nordisk-mit-starken-daten-20408246.html

Sep 07

Lose weight before it gets serious: Novo Nordisk with strong data: Novo Nordisk reports positive Phase 3 results for semaglutide in obese children ...

deraktionaer.de/artikel/pharma-biotech/eli-lilly-naechste-zulassung-noch-mehr-druck-fuer-novo-nordisk-20407704.html

Aug 31

Eli Lilly: Next approval - | even more pressure for Novo Nordisk: Eli Lilly receives approval for Mounjaro to reduce cardiovascular risks in type 2 diabetes.

manager-magazin.de/unternehmen/pharma/eli-lilly-us-konzern-im-hoehenflug-novo-nordisk-rechnet-mit-rueckgaengen-a-839421a1-543a-49a2-aec1-d4b8f1e13d41

Manager Magazin

Aug 06

Weight-loss medications: Eli Lilly soaring, Novo Nordisk in freefall: Novo Nordisk expects a sales decline of up to 6 percent. Competitor Eli Lilly ...

deraktionaer.de/artikel/aktien/novo-nordisk-prognose-rauf-aber-20406085.html

Aug 04

Novo Nordisk: Forecast up, but...: Novo Nordisk raises its sales forecast due to the success of the Wegovy weight-loss pill and now expects a decline of no more ...

18 similar articles

Reuters

Aug 03

Obesity battle heats up again as Novo claws way back into race with Lilly: Novo Nordisk investors have found little cause for optimism during a bruising two-year ...

reuters.com/legal/litigation/obesity-battle-heats-up-again-novo-claws-way-back-into-race-with-lilly-2026-08-03/

finanzen.net/nachricht/aktien/milliardenmarkt-novo-nordisk-aktie-faellt-dennoch-abnehmmittel-semaglutid-rueckt-in-den-fokus-der-lebermedizin-00-15699027

finanzen.net

May 20

Novo Nordisk stock falls nonetheless: Weight-loss drug semaglutide could also save the liver

qz.com/novo-nordisk-q1-2026-earnings-wegovy-pill-guidance-050626

Quartz

B+

May 06

Novo Nordisk beats earnings expectations and the stock surges on demand for weight loss pill

17 similar articles

0 0

finanzen.net

Apr 20

Novo Nordisk stock under pressure: Competition, IPO, pill race, billion-dollar deal: How the situation is changing for Novo Nordisk

finanzen.net/nachricht/aktien/adipositas-markt-novo-nordisk-aktie-unter-druck-wettbewerb-verschaerft-sich-neue-rivalen-neue-pillen-00-15620444

cnbc.com/2026/02/04/eli-lilly-novo-nordisk-earnings-glp1-market.html

CNBC

Feb 04

Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026

26 similar articles

1 4

Handelsblatt

B+

Nov 26 25

Pharma: Novo Nordisk scores with new weight-loss drug Amycretin in study: After a diabetes drug disappointed in an Alzheimer's study, Novo Nordisk has ...

handelsblatt.com/technik/forschung-innovation/pharma-novo-nordisk-punktet-mit-neuem-abnehmmittel-amycretin-in-studie/100178128.html